4-Bromocumene

We are 4-Bromocumene CAS:586-61-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Bromocumene
CAS.NO:586-61-8
Synonyms:P-BROMOCUMENE 
1-BROMO-4-ISOPROPYLBENZENE
Molecular Formula:C9H11Br
Molecular Weight:199.08800
 
Physical and Chemical Properties:
Density:1.286;
Melting point:-22oC;
Boiling point:103-104oC;
Flash point:100oF;
Index of Refraction:1.537;
 
Specification:
Appearance:Light yellow liquid
Purity(HPLC):≥98.5%
Moisture:≤0.5%
Residue on lgnition:≤0.5%
Total Impurnity:≤1.5%
Single impunty:≤1.0%
 
Packing:250 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As an intermediate in organic synthesis

4-Bromocumene


Related News: At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.2-Chloro-5-fluorobenzoic acid CAS:2252-50-8 At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate CAS:163521-20-8 From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.(R)-2-Amino-3-methoxypropanoic acid hydrochloride As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.

Related Products
Product Name
2′,3′-O-Isopropylideneadenosine View Details
2,4-dichloro-1-(dichloromethyl)benzene View Details
ethyl 3-(nitromethyl)hexanoate View Details
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, (1S,3S,5S)- manufacturer 2,4,5,6-Tetraaminopyrimidine sulfate manufacturer 1,5-Dibromo-2-fluoro-4-methoxybenzene manufacturer 5-Fluoro-2-hydroxypyridine manufacturer (Oxydi-2,1-phenylene)bis(diphenylphosphine) manufacturer